Carlsmed Inc. Common Stock
Financials
Valuation Metrics
Carlsmed Inc. Common Stock's Market Cap is $424M. At end of 2025 it was $176M. Ranked #2856 of 3,121 in US market (top 92%), #1266 of 1,463 on NASDAQ (top 87%), #175 of 205 in Health Care Equipment & Services (top 85%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $424M | US#2,856/3,121 Sec#175/205 |
| Revenue | $63M | US#2,755/3,121 Sec#192/205 |
| Net Income | $-36M | US—/3,121 Sec—/205 |
| Total Assets | $118M | US#3,052/3,121 Sec#197/205 |
| Net Assets | $84M | US#2,825/3,121 Sec#182/205 |
| Employees | 127 | US#2,586/3,121 Sec#179/205 |
| Value | ||
| P/B | 5.03x | US#2,219/3,121 Sec#135/205 |
| P/S | 6.69x | US#2,498/3,121 Sec#163/205 |
| FCF Yield | -8.08% | US—/3,121 Sec—/205 |
| Profitability | ||
| ROE | -43.14% | US#2,648/3,121 Sec#165/205 |
| ROA | -30.75% | US#2,891/3,121 Sec#188/205 |
| Op. Margin | -61.09% | US#2,695/3,121 Sec#184/205 |
| Revenue Growth | 65.39% | US#164/3,121 Sec#5/205 |
| Financial Health | ||
| Debt Ratio | 40.31% | US#461/3,121 Sec#50/205 |
| Total Debt | $22M | US#2,745/3,121 Sec#170/205 |
| FCF | $-34M | US#2,483/3,121 Sec#173/205 |
| Cash | $46M | US#2,608/3,121 Sec#166/205 |
| Current Ratio | 8.84x | US#297/3,121 Sec#19/205 |
| Performance | ||
| 1Y Return | 1.50% | US#1,742/3,121 Sec#121/205 |
| 1M Return | 0.39% | US#607/3,121 Sec#69/205 |
| From 52W High | -9.58% | US#772/3,121 Sec#67/205 |
| 1Y MDD | -48.03% | US#2,369/3,121 Sec#144/205 |
| Trading | ||
| Volume | 185,875 shares | US#2,990/3,121 Sec#200/205 |
| Trading Value | $3M | US#2,998/3,121 Sec#192/205 |
| Per Share | ||
| EPS | $-1.34 | US—/3,121 Sec—/205 |
| BPS | $3.10 | US#2,483/3,121 Sec#162/205 |
Company Info
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.